{"gene":"PF3D7_0911900","run_date":"2026-09-08T12:51:27","timeline":{"discoveries":[{"year":2006,"finding":"ICP (falstatin) expressed in E. coli is a potent reversible inhibitor of P. falciparum cysteine proteases falcipain-2 and falcipain-3, but a relatively weak inhibitor of falcipain-1 and dipeptidyl aminopeptidase 1, demonstrating selectivity among parasite cysteine proteases.","method":"In vitro enzymatic inhibition assay with recombinant protein expressed in E. coli","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstituted inhibition assays with recombinant protein, selectivity profiled across multiple substrates in a single rigorous study","pmids":["17083274"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2006,"finding":"ICP (falstatin) is present in schizonts, merozoites, and rings, but absent in trophozoites (the stage of maximal cysteine protease activity), localizes to the periphery of rings and early schizonts, is diffusely expressed in late schizonts and merozoites, and is released upon rupture of mature schizonts.","method":"Stage-specific localization by immunofluorescence/immunostaining and fractionation","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization experiment with stage-specific expression data; single lab, single method","pmids":["17083274"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2006,"finding":"Antibodies blocking ICP (falstatin) inhibitory activity against falcipain-2 and falcipain-3 dose-dependently decreased subsequent invasion of erythrocytes by merozoites, establishing that ICP facilitates erythrocyte invasion by controlling cysteine protease activity at the site of merozoite entry.","method":"Antibody blockade of inhibitory activity followed by erythrocyte invasion assay","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional blockade experiment with dose-dependent readout, combined with in vitro biochemical characterization in same study","pmids":["17083274"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2010,"finding":"P. berghei ICP (PbICP) is secreted by sporozoites prior to and after hepatocyte invasion, localizes to the parasitophorous vacuole and parasite cytoplasm in schizont stage, and is released into the host cell cytoplasm at the end of liver stage; it is posttranslationally processed, liberating the C-terminal chagasin-like domain.","method":"Immunofluorescence localization; biochemical fractionation; western blot for processed forms","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization and biochemical processing data, single lab, two orthogonal methods (imaging + biochemistry)","pmids":["20361051"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2010,"finding":"Pre-incubation with anti-PbICP antiserum significantly decreased sporozoite infectivity for hepatocytes, demonstrating that P. berghei ICP is required for sporozoite invasion of hepatocytes.","method":"Antibody blockade followed by hepatocyte infection assay","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional blockade experiment with defined cellular phenotype; single lab, single method","pmids":["20361051"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2010,"finding":"Expression of P. berghei ICP in mammalian cells protects them against peroxide- and camptothecin-induced cell death, indicating ICP can block host hepatocyte programmed cell death by inhibiting host cysteine proteases involved in apoptosis.","method":"Overexpression of PbICP in mammalian cells followed by chemically-induced apoptosis assay","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct gain-of-function experiment with specific cellular phenotype; single lab, single method","pmids":["20361051"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2010,"finding":"Both full-length PbICP and the truncated C-terminal chagasin-like domain are potent inhibitors of cathepsin L-like host and parasite cysteine proteases, establishing that the C-terminal domain is sufficient for protease inhibitory activity.","method":"In vitro enzymatic inhibition assay with recombinant full-length and truncated PbICP","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstituted activity assay with domain dissection; single lab","pmids":["20361051"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2011,"finding":"The 2.6 Å X-ray crystal structure of the C-terminal inhibitory domain of P. berghei ICP (PbICP-C) in a 1:1 complex with P. falciparum falcipain-2 establishes that Plasmodium ICP is a member of the I42 class of chagasin-like protease inhibitors, with large insertions and differences in binding mode relative to other family members; the structure also explains why cathepsin B-like proteases and the protease-like domain of SERA5 are not targets for ICP.","method":"X-ray crystallography at 2.6 Å resolution; structural analysis of protein-protein complex","journal":"Structure (London, England : 1993)","confidence":"High","confidence_rationale":"Tier 1 / Moderate — atomic-resolution crystal structure of inhibitor-protease complex with mechanistic interpretation of binding mode and selectivity","pmids":["21742259"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""},{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"finding":"P. yoelii ICP is refractory to targeted gene deletion, indicating an essential function during asexual blood-stage replication; it localizes to vesicles in the parasite cytoplasm, the parasitophorous vacuole, and is exported to dynamic exomembrane structures in infected red blood cells.","method":"Targeted gene deletion attempts; live fluorescence imaging for subcellular localization","journal":"Cellular microbiology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — gene deletion refractoriness combined with direct localization imaging; single lab","pmids":["23421981"],"is_preprint":false,"attribution":[{"species":"Plasmodium yoelii","strain":""}]},{"year":2013,"finding":"P. yoelii ICP localizes to rhoptries and intracellular vesicles distinct from TRAP-containing micronemes in sporozoites, and is confined to the parasite compartment during liver-stage development until parasitophorous vacuole membrane breakdown, when it is released into the infected hepatocyte.","method":"Fluorescence imaging; co-localization with known organelle markers","journal":"Cellular microbiology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization by fluorescence imaging with organelle markers; single lab, two life cycle stages examined","pmids":["23421981"],"is_preprint":false,"attribution":[{"species":"Plasmodium yoelii","strain":""}]},{"year":2013,"finding":"P. yoelii ICP physically interacts with the cysteine protease yoelipain-2 during asexual blood-stage infection, identifying yoelipain-2 as a binding partner.","method":"Co-immunoprecipitation / protein-protein interaction assay","journal":"Cellular microbiology","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — single Co-IP identifying binding partner; single lab","pmids":["23421981"],"is_preprint":false,"attribution":[{"species":"Plasmodium yoelii","strain":""}]},{"year":2013,"finding":"Targeted gene disruption of P. berghei ICP causes a complete defect in sporozoite transmission without affecting blood-stage growth; icp-null hemocoel sporozoites exhibit defective continuous gliding motility and inability to infect salivary glands, correlated with enhanced cleavage of circumsporozoite protein.","method":"Targeted gene disruption (reverse genetics); gliding motility assay; salivary gland infection assay; CSP cleavage assay by western blot","journal":"mBio","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean genetic knockout with multiple specific phenotypic readouts (motility, infectivity, CSP processing) in a single study","pmids":["24281719"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2014,"finding":"Stage-specific knockout of P. berghei ICP in sporozoites results in impaired hepatocyte invasion and failure of liver stage development; blood-stage parasites completely lacking ICP show attenuated growth; ICP-null sporozoites from oocysts have defective motility and cannot invade hepatocytes; transfection with a pbicp-gfp construct fully rescues all defects, confirming specificity.","method":"Stage-specific conditional gene knockout; rescue by transgenic complementation; hepatocyte invasion assay; motility assay","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic rescue (complementation) confirms specificity of multiple phenotypes (motility, invasion, development) across life cycle stages; independent replication of ICP role in sporozoite biology","pmids":["25166051"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2014,"finding":"Site-directed mutagenesis of ICP (falstatin) BC, DE, and FG loops demonstrates that the BC loop, but not the DE or FG loops, is responsible for inhibiting cysteine proteases of P. falciparum and P. vivax via hydrogen bonds; falstatin functions as a multimeric protein, the first known ICP to do so.","method":"Site-directed mutagenesis; hemoglobin hydrolysis assays; peptide inhibition studies","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — active-site mutagenesis combined with enzymatic assays identifying the inhibitory hot-spot and multimeric nature; single lab with multiple orthogonal methods","pmids":["24699522"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2024,"finding":"The N-terminal region of ICP (falstatin) is highly disordered and requires chaperone activity of HSP70 for folding; protein-protein interaction assays confirmed a significant interaction between falstatin and HSP70. Biophysical characterization revealed that falstatin forms an extremely thermostable decamer composed of five head-to-tail dimers, with the C-terminal region primarily driving oligomerization. Stoichiometric analysis showed that the FP2-falstatin multimer forms a heterooligomeric complex in a 1:1 ratio with ten subunits of each protein.","method":"Protein-protein interaction assays; biophysical characterization (multiple techniques); computational modeling; stoichiometric analysis","journal":"International journal of biological macromolecules","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal biophysical methods characterizing multimeric complex, single lab; complemented by computational analysis","pmids":["38460641"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"current_model":"ICP (falstatin/PF3D7_0911900) is a chagasin-class (I42) cysteine protease inhibitor that forms a thermostable decamer (requiring HSP70 for folding of its disordered N-terminus) and inhibits falcipain-2 and falcipain-3 via its BC loop through hydrogen bonds; it is expressed in a stage-specific manner (absent in trophozoites), is exported to exomembrane structures and the parasitophorous vacuole, is essential for sporozoite gliding motility and salivary gland infectivity in the mosquito vector, facilitates erythrocyte invasion by controlling proteolysis at the merozoite surface, and in liver stages protects host hepatocytes from apoptosis by inhibiting host cathepsin L-like proteases."},"narrative":{"mechanistic_narrative":"PF3D7_0911900 (ICP, falstatin) is a chagasin-class (I42) cysteine protease inhibitor that regulates Plasmodium proteolysis across multiple stages of the parasite life cycle by selectively inhibiting parasite and host papain-family cysteine proteases [PMID:17083274, PMID:21742259]. The recombinant P. falciparum protein is a potent, reversible, and selective inhibitor of the falcipain-2 and falcipain-3 cysteine proteases, while sparing falcipain-1 and dipeptidyl aminopeptidase 1 [PMID:17083274]; inhibition is mediated by the BC loop, which contacts the target protease through hydrogen bonds, whereas the DE and FG loops are dispensable [PMID:24699522]. A 2.6 Å crystal structure of the C-terminal inhibitory domain in complex with falcipain-2 establishes ICP as an I42 chagasin-like inhibitor and rationalizes its selectivity against cathepsin B-like proteases and the SERA5 protease-like domain [PMID:21742259], and the C-terminal domain alone is sufficient for inhibitory activity [PMID:20361051]. Unusually, falstatin functions as a multimer, assembling into a thermostable decamer of five head-to-tail dimers whose oligomerization is driven by the C-terminal region and whose disordered N-terminus requires HSP70 for folding; it forms a 1:1 stoichiometric heterooligomer with ten subunits each of falcipain-2 and falstatin [PMID:24699522, PMID:38460641]. ICP is expressed in a stage-specific manner during blood stages—present in schizonts, merozoites, and rings but absent in trophozoites—and is released on schizont rupture; antibody blockade of its inhibitory activity reduces erythrocyte invasion, implicating ICP in controlling proteolysis at the site of merozoite entry [PMID:17083274]. Across rodent-malaria orthologs, ICP is essential and multifunctional: in P. yoelii and P. berghei it localizes to cytoplasmic vesicles, rhoptries, the parasitophorous vacuole, and exported exomembrane structures, and is released into host hepatocytes upon vacuole breakdown [PMID:23421981, PMID:20361051]; genetic disruption in P. berghei abolishes sporozoite transmission through defective gliding motility, salivary-gland infectivity, and hepatocyte invasion (with enhanced circumsporozoite protein cleavage), all rescued by complementation, while blood-stage growth is attenuated [PMID:24281719, PMID:25166051]. In addition to inhibiting parasite proteases such as yoelipain-2 [PMID:23421981], P. berghei ICP inhibits host cathepsin L-like cysteine proteases and, when expressed in mammalian cells, protects them from induced apoptosis [PMID:20361051].","teleology":[{"year":2006,"claim":"Establishing ICP's biochemical identity required showing whether it is a genuine, selective protease inhibitor; recombinant assays defined it as a potent, reversible, selective inhibitor of falcipain-2 and falcipain-3.","evidence":"In vitro enzymatic inhibition assays with E. coli-expressed recombinant protein across multiple parasite cysteine proteases","pmids":["17083274"],"confidence":"High","gaps":["Molecular basis of selectivity not yet defined","In vivo substrates during the life cycle not established"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2006,"claim":"To connect biochemistry to parasite biology, its expression pattern and a functional role were tested; ICP is stage-specific (absent in the trophozoite stage of maximal protease activity) and its inhibitory activity is needed for efficient erythrocyte invasion.","evidence":"Stage-specific immunolocalization/fractionation and antibody-blockade erythrocyte invasion assays","pmids":["17083274"],"confidence":"High","gaps":["Direct genetic evidence for the invasion role in P. falciparum absent","Which merozoite-surface proteolytic events ICP controls not identified"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2010,"claim":"Whether ICP acts beyond blood stages was unknown; work in P. berghei showed the ortholog is secreted by sporozoites, processed to liberate its C-terminal chagasin-like domain, released into host hepatocyte cytoplasm, and can block host apoptosis via cathepsin L-like protease inhibition.","evidence":"Immunofluorescence, fractionation, western blot for processing, in vitro inhibition of full-length and truncated protein, and induced-apoptosis assays in mammalian cells","pmids":["20361051"],"confidence":"Medium","gaps":["Host protease target(s) mediating apoptosis protection not identified","Physiological relevance of apoptosis protection in vivo not established","Single-lab, single-method localization"],"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2011,"claim":"The structural basis of inhibition and family assignment were unresolved; the crystal structure of the C-terminal domain bound to falcipain-2 placed Plasmodium ICP in the I42 chagasin class and explained its target selectivity.","evidence":"2.6 Å X-ray crystallography of the PbICP-C:falcipain-2 complex","pmids":["21742259"],"confidence":"High","gaps":["Structure of full-length multimeric protein not resolved","Role of N-terminal region not addressed by the structure"],"attribution":[{"species":"Plasmodium berghei","strain":""},{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"claim":"Direct genetic requirement and additional binding partners were unknown; refractoriness to deletion, exomembrane/vesicular localization, and interaction with yoelipain-2 established an essential blood-stage role and a new protease partner in P. yoelii.","evidence":"Targeted gene deletion attempts, live and marker co-localization imaging, and co-immunoprecipitation in P. yoelii","pmids":["23421981"],"confidence":"Medium","gaps":["Essentiality inferred from deletion refractoriness rather than conditional knockout","yoelipain-2 interaction from single Co-IP without reciprocal validation"],"attribution":[{"species":"Plasmodium yoelii","strain":""}]},{"year":2013,"claim":"Whether ICP has stage-specific functions in transmission was untested; clean genetic disruption in P. berghei showed it is required for sporozoite gliding motility and salivary-gland infectivity, correlating with excess circumsporozoite protein cleavage, without affecting blood-stage growth.","evidence":"Targeted gene disruption with gliding motility, salivary gland infection, and CSP cleavage assays in P. berghei","pmids":["24281719"],"confidence":"High","gaps":["Protease responsible for CSP over-cleavage not identified","Mechanism linking protease inhibition to motility not resolved"],"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2014,"claim":"To confirm specificity and map the inhibitory determinant, conditional knockout/rescue and loop mutagenesis were performed; stage-specific knockout impaired hepatocyte invasion and liver-stage development (fully rescued by complementation), and the BC loop was identified as the inhibitory hot-spot, with falstatin found to act as a multimer.","evidence":"Conditional knockout with transgenic complementation and invasion/motility assays in P. berghei; site-directed BC/DE/FG loop mutagenesis with hemoglobin hydrolysis and peptide inhibition assays in P. falciparum/P. vivax","pmids":["25166051","24699522"],"confidence":"High","gaps":["Functional consequence of multimerization for inhibition not defined at this stage","Blood-stage attenuation mechanism not resolved"],"attribution":[{"species":"Plasmodium berghei","strain":""},{"species":"Plasmodium falciparum","strain":""}]},{"year":2024,"claim":"The oligomeric architecture and folding requirements were unclear; biophysical work showed the N-terminus is disordered and HSP70-dependent for folding, the protein forms a thermostable decamer of five head-to-tail dimers driven by the C-terminus, and binds falcipain-2 as a 1:1 ten-subunit heterooligomer.","evidence":"Protein-protein interaction assays, multiple biophysical techniques, computational modeling, and stoichiometric analysis in P. falciparum","pmids":["38460641"],"confidence":"Medium","gaps":["In vivo role of HSP70-assisted folding not established","Functional significance of the decameric assembly for pathogen biology not demonstrated"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"It remains unresolved which endogenous parasite and host proteases ICP controls at each life-cycle transition and how its multimeric assembly and stage-specific export are regulated to achieve stage-appropriate proteolytic control.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Physiological substrate set per stage not defined","Regulation of export and multimerization unknown","Direct genetic proof of the erythrocyte-invasion role in P. falciparum absent"],"attribution":[]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":["Falstatin decamer (five head-to-tail dimers) [#14]","Falcipain-2:falstatin 1:1 heterooligomer (ten subunits each) [#7, #14]"],"partners":["FALCIPAIN-2 [#0, #7, #14]","FALCIPAIN-3 [#0]","YOELIPAIN-2 (P. YOELII) [#10]","HSP70 [#14]","HOST CATHEPSIN L-LIKE CYSTEINE PROTEASES [#5, #6]"],"other_free_text":["Chagasin-class (I42) cysteine protease inhibitor; C-terminal domain sufficient for inhibition, BC loop is the inhibitory hot-spot acting via hydrogen bonds [#6, #7, #13].","Stage-specific blood-stage expression: present in schizonts, merozoites, rings; absent in trophozoites; released on schizont rupture [#1].","Essential across rodent malaria orthologs: refractory to deletion in P. yoelii and required for sporozoite motility, salivary-gland infectivity, hepatocyte invasion, and liver-stage development in P. berghei, with attenuated blood-stage growth [#8, #11, #12].","Findings span P. falciparum (biochemistry, structure, multimerization, invasion), P. berghei (secretion, apoptosis protection, transmission/liver-stage genetics), and P. yoelii (essentiality, localization, yoelipain-2 interaction); species should not be merged."]}},"prefetch_data":{},"corpus_meta":[{"pmid":"17083274","id":"PMC_17083274","title":"Falstatin, a cysteine protease inhibitor of Plasmodium falciparum, facilitates erythrocyte invasion.","date":"2006","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/17083274","citation_count":72,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["falstatin"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20361051","id":"PMC_20361051","title":"Exoerythrocytic Plasmodium parasites secrete a cysteine protease inhibitor involved in sporozoite invasion and capable of blocking cell death of host hepatocytes.","date":"2010","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/20361051","citation_count":58,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["falstatin"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21742259","id":"PMC_21742259","title":"Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium.","date":"2011","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/21742259","citation_count":31,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ICP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23421981","id":"PMC_23421981","title":"Plasmodium yoelii inhibitor of cysteine proteases is exported to exomembrane structures and interacts with yoelipain-2 during asexual blood-stage development.","date":"2013","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/23421981","citation_count":23,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ICP","falstatin"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24281719","id":"PMC_24281719","title":"Inhibitor of cysteine proteases is critical for motility and infectivity of Plasmodium sporozoites.","date":"2013","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/24281719","citation_count":23,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ICP","falstatin"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"25166051","id":"PMC_25166051","title":"A cysteine protease inhibitor of plasmodium berghei is essential for exo-erythrocytic development.","date":"2014","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/25166051","citation_count":21,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ICP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24699522","id":"PMC_24699522","title":"Cross-talk between malarial cysteine proteases and falstatin: the BC loop as a hot-spot target.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24699522","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ICP","falstatin"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"31936739","id":"PMC_31936739","title":"Synthetic DNA Vaccines Adjuvanted with pIL-33 Drive Liver-Localized T Cells and Provide Protection from Plasmodium Challenge in a Mouse Model.","date":"2020","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/31936739","citation_count":4,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ICP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"22102243","id":"PMC_22102243","title":"The macromolecular complex of ICP and falcipain-2 from Plasmodium: preparation, crystallization and preliminary X-ray diffraction analysis.","date":"2011","source":"Acta crystallographica. Section F, Structural biology and crystallization communications","url":"https://pubmed.ncbi.nlm.nih.gov/22102243","citation_count":3,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ICP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"38460641","id":"PMC_38460641","title":"Understanding the complex formation of falstatin; an endogenous macromolecular inhibitor of falcipains.","date":"2024","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/38460641","citation_count":2,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["falstatin"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"42550035","id":"PMC_42550035","title":"Sero-epidemiological and functional evaluation of IgG specific for a cysteine protease inhibitor of Plasmodium falciparum, falstatin.","date":"2026","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/42550035","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["falstatin","inhibitor of cysteine proteases"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8445,"output_tokens":3812,"usd":0.041258,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9866,"output_tokens":4501,"usd":0.080927,"stage2_stop_reason":"end_turn"},"total_usd":0.122185,"stage1_batch_id":"msgbatch_01DisAaTypwmC8QwdMBuePHo","stage2_batch_id":"msgbatch_0184zxZTqxiEfdYYfPMfkqjb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"ICP (falstatin) expressed in E. coli is a potent reversible inhibitor of P. falciparum cysteine proteases falcipain-2 and falcipain-3, but a relatively weak inhibitor of falcipain-1 and dipeptidyl aminopeptidase 1, demonstrating selectivity among parasite cysteine proteases.\",\n      \"method\": \"In vitro enzymatic inhibition assay with recombinant protein expressed in E. coli\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstituted inhibition assays with recombinant protein, selectivity profiled across multiple substrates in a single rigorous study\",\n      \"pmids\": [\"17083274\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ICP (falstatin) is present in schizonts, merozoites, and rings, but absent in trophozoites (the stage of maximal cysteine protease activity), localizes to the periphery of rings and early schizonts, is diffusely expressed in late schizonts and merozoites, and is released upon rupture of mature schizonts.\",\n      \"method\": \"Stage-specific localization by immunofluorescence/immunostaining and fractionation\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization experiment with stage-specific expression data; single lab, single method\",\n      \"pmids\": [\"17083274\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Antibodies blocking ICP (falstatin) inhibitory activity against falcipain-2 and falcipain-3 dose-dependently decreased subsequent invasion of erythrocytes by merozoites, establishing that ICP facilitates erythrocyte invasion by controlling cysteine protease activity at the site of merozoite entry.\",\n      \"method\": \"Antibody blockade of inhibitory activity followed by erythrocyte invasion assay\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional blockade experiment with dose-dependent readout, combined with in vitro biochemical characterization in same study\",\n      \"pmids\": [\"17083274\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"P. berghei ICP (PbICP) is secreted by sporozoites prior to and after hepatocyte invasion, localizes to the parasitophorous vacuole and parasite cytoplasm in schizont stage, and is released into the host cell cytoplasm at the end of liver stage; it is posttranslationally processed, liberating the C-terminal chagasin-like domain.\",\n      \"method\": \"Immunofluorescence localization; biochemical fractionation; western blot for processed forms\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization and biochemical processing data, single lab, two orthogonal methods (imaging + biochemistry)\",\n      \"pmids\": [\"20361051\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Pre-incubation with anti-PbICP antiserum significantly decreased sporozoite infectivity for hepatocytes, demonstrating that P. berghei ICP is required for sporozoite invasion of hepatocytes.\",\n      \"method\": \"Antibody blockade followed by hepatocyte infection assay\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional blockade experiment with defined cellular phenotype; single lab, single method\",\n      \"pmids\": [\"20361051\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Expression of P. berghei ICP in mammalian cells protects them against peroxide- and camptothecin-induced cell death, indicating ICP can block host hepatocyte programmed cell death by inhibiting host cysteine proteases involved in apoptosis.\",\n      \"method\": \"Overexpression of PbICP in mammalian cells followed by chemically-induced apoptosis assay\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct gain-of-function experiment with specific cellular phenotype; single lab, single method\",\n      \"pmids\": [\"20361051\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Both full-length PbICP and the truncated C-terminal chagasin-like domain are potent inhibitors of cathepsin L-like host and parasite cysteine proteases, establishing that the C-terminal domain is sufficient for protease inhibitory activity.\",\n      \"method\": \"In vitro enzymatic inhibition assay with recombinant full-length and truncated PbICP\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstituted activity assay with domain dissection; single lab\",\n      \"pmids\": [\"20361051\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The 2.6 Å X-ray crystal structure of the C-terminal inhibitory domain of P. berghei ICP (PbICP-C) in a 1:1 complex with P. falciparum falcipain-2 establishes that Plasmodium ICP is a member of the I42 class of chagasin-like protease inhibitors, with large insertions and differences in binding mode relative to other family members; the structure also explains why cathepsin B-like proteases and the protease-like domain of SERA5 are not targets for ICP.\",\n      \"method\": \"X-ray crystallography at 2.6 Å resolution; structural analysis of protein-protein complex\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — atomic-resolution crystal structure of inhibitor-protease complex with mechanistic interpretation of binding mode and selectivity\",\n      \"pmids\": [\"21742259\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}, {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"P. yoelii ICP is refractory to targeted gene deletion, indicating an essential function during asexual blood-stage replication; it localizes to vesicles in the parasite cytoplasm, the parasitophorous vacuole, and is exported to dynamic exomembrane structures in infected red blood cells.\",\n      \"method\": \"Targeted gene deletion attempts; live fluorescence imaging for subcellular localization\",\n      \"journal\": \"Cellular microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — gene deletion refractoriness combined with direct localization imaging; single lab\",\n      \"pmids\": [\"23421981\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium yoelii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"P. yoelii ICP localizes to rhoptries and intracellular vesicles distinct from TRAP-containing micronemes in sporozoites, and is confined to the parasite compartment during liver-stage development until parasitophorous vacuole membrane breakdown, when it is released into the infected hepatocyte.\",\n      \"method\": \"Fluorescence imaging; co-localization with known organelle markers\",\n      \"journal\": \"Cellular microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization by fluorescence imaging with organelle markers; single lab, two life cycle stages examined\",\n      \"pmids\": [\"23421981\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium yoelii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"P. yoelii ICP physically interacts with the cysteine protease yoelipain-2 during asexual blood-stage infection, identifying yoelipain-2 as a binding partner.\",\n      \"method\": \"Co-immunoprecipitation / protein-protein interaction assay\",\n      \"journal\": \"Cellular microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP identifying binding partner; single lab\",\n      \"pmids\": [\"23421981\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium yoelii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Targeted gene disruption of P. berghei ICP causes a complete defect in sporozoite transmission without affecting blood-stage growth; icp-null hemocoel sporozoites exhibit defective continuous gliding motility and inability to infect salivary glands, correlated with enhanced cleavage of circumsporozoite protein.\",\n      \"method\": \"Targeted gene disruption (reverse genetics); gliding motility assay; salivary gland infection assay; CSP cleavage assay by western blot\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic knockout with multiple specific phenotypic readouts (motility, infectivity, CSP processing) in a single study\",\n      \"pmids\": [\"24281719\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Stage-specific knockout of P. berghei ICP in sporozoites results in impaired hepatocyte invasion and failure of liver stage development; blood-stage parasites completely lacking ICP show attenuated growth; ICP-null sporozoites from oocysts have defective motility and cannot invade hepatocytes; transfection with a pbicp-gfp construct fully rescues all defects, confirming specificity.\",\n      \"method\": \"Stage-specific conditional gene knockout; rescue by transgenic complementation; hepatocyte invasion assay; motility assay\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic rescue (complementation) confirms specificity of multiple phenotypes (motility, invasion, development) across life cycle stages; independent replication of ICP role in sporozoite biology\",\n      \"pmids\": [\"25166051\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Site-directed mutagenesis of ICP (falstatin) BC, DE, and FG loops demonstrates that the BC loop, but not the DE or FG loops, is responsible for inhibiting cysteine proteases of P. falciparum and P. vivax via hydrogen bonds; falstatin functions as a multimeric protein, the first known ICP to do so.\",\n      \"method\": \"Site-directed mutagenesis; hemoglobin hydrolysis assays; peptide inhibition studies\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — active-site mutagenesis combined with enzymatic assays identifying the inhibitory hot-spot and multimeric nature; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"24699522\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The N-terminal region of ICP (falstatin) is highly disordered and requires chaperone activity of HSP70 for folding; protein-protein interaction assays confirmed a significant interaction between falstatin and HSP70. Biophysical characterization revealed that falstatin forms an extremely thermostable decamer composed of five head-to-tail dimers, with the C-terminal region primarily driving oligomerization. Stoichiometric analysis showed that the FP2-falstatin multimer forms a heterooligomeric complex in a 1:1 ratio with ten subunits of each protein.\",\n      \"method\": \"Protein-protein interaction assays; biophysical characterization (multiple techniques); computational modeling; stoichiometric analysis\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal biophysical methods characterizing multimeric complex, single lab; complemented by computational analysis\",\n      \"pmids\": [\"38460641\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"ICP (falstatin/PF3D7_0911900) is a chagasin-class (I42) cysteine protease inhibitor that forms a thermostable decamer (requiring HSP70 for folding of its disordered N-terminus) and inhibits falcipain-2 and falcipain-3 via its BC loop through hydrogen bonds; it is expressed in a stage-specific manner (absent in trophozoites), is exported to exomembrane structures and the parasitophorous vacuole, is essential for sporozoite gliding motility and salivary gland infectivity in the mosquito vector, facilitates erythrocyte invasion by controlling proteolysis at the merozoite surface, and in liver stages protects host hepatocytes from apoptosis by inhibiting host cathepsin L-like proteases.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PF3D7_0911900 (ICP, falstatin) is a chagasin-class (I42) cysteine protease inhibitor that regulates Plasmodium proteolysis across multiple stages of the parasite life cycle by selectively inhibiting parasite and host papain-family cysteine proteases [#0, #7]. The recombinant P. falciparum protein is a potent, reversible, and selective inhibitor of the falcipain-2 and falcipain-3 cysteine proteases, while sparing falcipain-1 and dipeptidyl aminopeptidase 1 [#0]; inhibition is mediated by the BC loop, which contacts the target protease through hydrogen bonds, whereas the DE and FG loops are dispensable [#13]. A 2.6 Å crystal structure of the C-terminal inhibitory domain in complex with falcipain-2 establishes ICP as an I42 chagasin-like inhibitor and rationalizes its selectivity against cathepsin B-like proteases and the SERA5 protease-like domain [#7], and the C-terminal domain alone is sufficient for inhibitory activity [#6]. Unusually, falstatin functions as a multimer, assembling into a thermostable decamer of five head-to-tail dimers whose oligomerization is driven by the C-terminal region and whose disordered N-terminus requires HSP70 for folding; it forms a 1:1 stoichiometric heterooligomer with ten subunits each of falcipain-2 and falstatin [#13, #14]. ICP is expressed in a stage-specific manner during blood stages—present in schizonts, merozoites, and rings but absent in trophozoites—and is released on schizont rupture; antibody blockade of its inhibitory activity reduces erythrocyte invasion, implicating ICP in controlling proteolysis at the site of merozoite entry [#1, #2]. Across rodent-malaria orthologs, ICP is essential and multifunctional: in P. yoelii and P. berghei it localizes to cytoplasmic vesicles, rhoptries, the parasitophorous vacuole, and exported exomembrane structures, and is released into host hepatocytes upon vacuole breakdown [#8, #9, #3]; genetic disruption in P. berghei abolishes sporozoite transmission through defective gliding motility, salivary-gland infectivity, and hepatocyte invasion (with enhanced circumsporozoite protein cleavage), all rescued by complementation, while blood-stage growth is attenuated [#11, #12]. In addition to inhibiting parasite proteases such as yoelipain-2 [#10], P. berghei ICP inhibits host cathepsin L-like cysteine proteases and, when expressed in mammalian cells, protects them from induced apoptosis [#5, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Establishing ICP's biochemical identity required showing whether it is a genuine, selective protease inhibitor; recombinant assays defined it as a potent, reversible, selective inhibitor of falcipain-2 and falcipain-3.\",\n      \"evidence\": \"In vitro enzymatic inhibition assays with E. coli-expressed recombinant protein across multiple parasite cysteine proteases\",\n      \"pmids\": [\"17083274\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of selectivity not yet defined\", \"In vivo substrates during the life cycle not established\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"To connect biochemistry to parasite biology, its expression pattern and a functional role were tested; ICP is stage-specific (absent in the trophozoite stage of maximal protease activity) and its inhibitory activity is needed for efficient erythrocyte invasion.\",\n      \"evidence\": \"Stage-specific immunolocalization/fractionation and antibody-blockade erythrocyte invasion assays\",\n      \"pmids\": [\"17083274\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct genetic evidence for the invasion role in P. falciparum absent\", \"Which merozoite-surface proteolytic events ICP controls not identified\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Whether ICP acts beyond blood stages was unknown; work in P. berghei showed the ortholog is secreted by sporozoites, processed to liberate its C-terminal chagasin-like domain, released into host hepatocyte cytoplasm, and can block host apoptosis via cathepsin L-like protease inhibition.\",\n      \"evidence\": \"Immunofluorescence, fractionation, western blot for processing, in vitro inhibition of full-length and truncated protein, and induced-apoptosis assays in mammalian cells\",\n      \"pmids\": [\"20361051\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Host protease target(s) mediating apoptosis protection not identified\", \"Physiological relevance of apoptosis protection in vivo not established\", \"Single-lab, single-method localization\"],\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The structural basis of inhibition and family assignment were unresolved; the crystal structure of the C-terminal domain bound to falcipain-2 placed Plasmodium ICP in the I42 chagasin class and explained its target selectivity.\",\n      \"evidence\": \"2.6 Å X-ray crystallography of the PbICP-C:falcipain-2 complex\",\n      \"pmids\": [\"21742259\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of full-length multimeric protein not resolved\", \"Role of N-terminal region not addressed by the structure\"],\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}, {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Direct genetic requirement and additional binding partners were unknown; refractoriness to deletion, exomembrane/vesicular localization, and interaction with yoelipain-2 established an essential blood-stage role and a new protease partner in P. yoelii.\",\n      \"evidence\": \"Targeted gene deletion attempts, live and marker co-localization imaging, and co-immunoprecipitation in P. yoelii\",\n      \"pmids\": [\"23421981\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Essentiality inferred from deletion refractoriness rather than conditional knockout\", \"yoelipain-2 interaction from single Co-IP without reciprocal validation\"],\n      \"attribution\": [{\"species\": \"Plasmodium yoelii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Whether ICP has stage-specific functions in transmission was untested; clean genetic disruption in P. berghei showed it is required for sporozoite gliding motility and salivary-gland infectivity, correlating with excess circumsporozoite protein cleavage, without affecting blood-stage growth.\",\n      \"evidence\": \"Targeted gene disruption with gliding motility, salivary gland infection, and CSP cleavage assays in P. berghei\",\n      \"pmids\": [\"24281719\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protease responsible for CSP over-cleavage not identified\", \"Mechanism linking protease inhibition to motility not resolved\"],\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"To confirm specificity and map the inhibitory determinant, conditional knockout/rescue and loop mutagenesis were performed; stage-specific knockout impaired hepatocyte invasion and liver-stage development (fully rescued by complementation), and the BC loop was identified as the inhibitory hot-spot, with falstatin found to act as a multimer.\",\n      \"evidence\": \"Conditional knockout with transgenic complementation and invasion/motility assays in P. berghei; site-directed BC/DE/FG loop mutagenesis with hemoglobin hydrolysis and peptide inhibition assays in P. falciparum/P. vivax\",\n      \"pmids\": [\"25166051\", \"24699522\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of multimerization for inhibition not defined at this stage\", \"Blood-stage attenuation mechanism not resolved\"],\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}, {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"The oligomeric architecture and folding requirements were unclear; biophysical work showed the N-terminus is disordered and HSP70-dependent for folding, the protein forms a thermostable decamer of five head-to-tail dimers driven by the C-terminus, and binds falcipain-2 as a 1:1 ten-subunit heterooligomer.\",\n      \"evidence\": \"Protein-protein interaction assays, multiple biophysical techniques, computational modeling, and stoichiometric analysis in P. falciparum\",\n      \"pmids\": [\"38460641\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo role of HSP70-assisted folding not established\", \"Functional significance of the decameric assembly for pathogen biology not demonstrated\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved which endogenous parasite and host proteases ICP controls at each life-cycle transition and how its multimeric assembly and stage-specific export are regulated to achieve stage-appropriate proteolytic control.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological substrate set per stage not defined\", \"Regulation of export and multimerization unknown\", \"Direct genetic proof of the erythrocyte-invasion role in P. falciparum absent\"],\n      \"attribution\": []\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0004869\", \"supporting_discovery_ids\": [0, 6, 7, 13]},\n      {\"term_id\": \"GO:0042803\", \"supporting_discovery_ids\": [13, 14]},\n      {\"term_id\": \"GO:0051087\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0020003\", \"supporting_discovery_ids\": [3, 8, 9]},\n      {\"term_id\": \"GO:0020002\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0020008\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0044409\", \"supporting_discovery_ids\": [2, 4, 11, 12]},\n      {\"term_id\": \"GO:0043066\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0071693\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"complexes\": [\n      \"Falstatin decamer (five head-to-tail dimers) [#14]\",\n      \"Falcipain-2:falstatin 1:1 heterooligomer (ten subunits each) [#7, #14]\"\n    ],\n    \"partners\": [\n      \"Falcipain-2 [#0, #7, #14]\",\n      \"Falcipain-3 [#0]\",\n      \"Yoelipain-2 (P. yoelii) [#10]\",\n      \"HSP70 [#14]\",\n      \"Host cathepsin L-like cysteine proteases [#5, #6]\"\n    ],\n    \"other_free_text\": [\n      \"Chagasin-class (I42) cysteine protease inhibitor; C-terminal domain sufficient for inhibition, BC loop is the inhibitory hot-spot acting via hydrogen bonds [#6, #7, #13].\",\n      \"Stage-specific blood-stage expression: present in schizonts, merozoites, rings; absent in trophozoites; released on schizont rupture [#1].\",\n      \"Essential across rodent malaria orthologs: refractory to deletion in P. yoelii and required for sporozoite motility, salivary-gland infectivity, hepatocyte invasion, and liver-stage development in P. berghei, with attenuated blood-stage growth [#8, #11, #12].\",\n      \"Findings span P. falciparum (biochemistry, structure, multimerization, invasion), P. berghei (secretion, apoptosis protection, transmission/liver-stage genetics), and P. yoelii (essentiality, localization, yoelipain-2 interaction); species should not be merged.\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_0911900","name":null,"product":"falstatin","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PbANKA","gene_id":"PBANKA_0813000","name":null,"product":"inhibitor of cysteine proteases","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PkH","gene_id":"PKNH_0709900","name":null,"product":"inhibitor of cysteine proteases, putative","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"ICP","evaluation":null}